Silgan (SLGN) Q1 2025 earnings summary

Executive summary

• Achieved record Q1 2025 results with net sales of $1.47 billion, up 11.4% year-over-year, driven by the Weener acquisition, organic volume growth, and cost savings.

• Adjusted EPS reached $0.82, a 19% increase, with all segments contributing to growth and Dispensing and Specialty Closures showing particular strength.

• Integration of the Weener acquisition is progressing well, providing incremental growth and synergy opportunities.

• Gross profit margin improved to 18.4% from 17.0% year-over-year, reflecting productivity and product mix gains.

• Management reaffirmed expectations for double-digit earnings and free cash flow growth for 2025.

Financial highlights

• Net sales reached $1.47 billion, up 11.4% year-over-year, primarily due to the Weener acquisition and organic growth.

• Adjusted EBIT was $158.3 million, up from $135.5 million, with margin expansion across all segments.

• Adjusted EPS was $0.82, a 19% increase from the prior year quarter.

• Gross profit improved to $270.4 million from $223.5 million; gross margin expanded.

• Net income for Q1 2025 was $68.0 million, up from $55.2 million in Q1 2024; diluted EPS was $0.63 versus $0.52.

Outlook and guidance

• 2025 adjusted EPS guidance confirmed at $4.00–$4.20, a 13% increase at midpoint over 2024.

• Free cash flow for 2025 expected at $450 million, up 15% year-over-year, with CapEx of $300 million.

• Q2 2025 adjusted EPS expected in the range of $0.98–$1.08, a 17% year-over-year increase.

• Management expects sufficient liquidity from operations and credit facilities to meet all obligations.

• Mid-single-digit volume growth expected in all segments for 2025, with metal containers volumes flat in Q2 and growth weighted to the second half.